Introduction:
The prevalence of type 2 DM is undergoing a rapid progression Results of the study: § This study was carried on 200 cases with type 2 diabetes mellitus 113 males, 87 females , their ages ranged from 33 to 75 years were collected from the outpatient diabetic clinic of sohag university hospital. Statistical package for social sciences (IBM-SPSS), version 24 IBM-Chicago, USA (May 2016) was used for statistical data analysis. § Data expressed as mean, standard deviation (SD), number and percentage. Mean and standard deviation were used as descriptive value for quantitative data, while number and percentage were used to describe qualitative data. § Student t test was used to compare the means between two groups, and one-way analysis of variance (ANOVA) test with post HOC tests were used to compare means of more than two groups. § Pearson Chi square was used to compare percentages of qualitative data. § ROC curve analysis was used to predict the value of CMI to differentiate diabetic or obese or both patients from non diabetics, or non obese ones. § For all these tests, the level of significance (P-value) can be explained as:
o No significance P > 0.05 § .001 § This table shows that BMI was much higher among group 2 compared to both groups 1 and 3, and also, it was significantly higher among group 1 compared to group 3. 
2013).
The main objective of this trial is to investigate relationships between plasma lipid levels and diabetes prevalence in patients attending to our out-patient clinic because we are interested in the relationship between diabetes and dyslipidemia, cardiometabolic syndrome. This study included three groups (diabetic, non diabetics, and controls). There was no significant difference between the three groups regarding the mean age as it was 53 years in all groups, also in study of Kumar et al. (2016) mean age of their patients was 50.3 years with range 25-85 years. In diabetic patients, several researches have evidently established that complications are mainly due to chronic hyperglycemia that exerts its adverse to health effects through numerous mechanisms: dyslipidemia, platelet activation, and altered endothelial metabolism (Ozder. 2014).
In our study group 2 (diabetic obese) showed the worst values for both lipid profile and HbA1c, followed by group 1 (diabetic non obese) and group 3 (controls) showed the best figures. Also BMI was much higher among group 2 (diabetic obese) compared to both groups 1 and 3. Similar to observations in other population, our study demonstrated that TG&HDL was much higher among group 2 (diabetic obese) compared to both groups 1 and 3, and also waist/height, CMI, were significantly higher among group 1 compared to group 3, this was in agreement with study of Jain et al. (2016) as they shown that TG, TC, LDL-C, and VLDL-C, the lipid profile was higher significantly in diabetes than and HDL-C was significantly lower in diabetics than control groups. In study of Abdel-Aal et al. (2008) they reported higher mean serum levels of LDL, cholesterol, total cholesterol, and triglycerides were noted in patients with diabetes, which are well known risk factors for cardiovascular diseases among diabetic patients. Higher level of LDL (34.9%) and hypercholesterolemia (34.6%) were the most frequent and found almost in similar proportion in all diabetic patients. The third prevalent dyslipidemia was hypertriglyceridemia affecting 29.8% of their studied subjects. Their findings of hypercholesterolemia and hypertriglyceridemia were almost half way between two studies from Ethiopia 
Conclusion:
Diabetes is a well-established independent risk factor for cardiovascular diseases (CVD). Compared with non-diabetic individuals, diabetic patients have 2 to 4 times increased risk for stroke and death from heart disease. 
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